ACCESS Newswire
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
📊
AI Sentiment
Positive
6/10
- Home
- MDCX
as of 12-09-2025 2:03pm EST
$2.06
+$0.02
+1.11%
Stocks Nasdaq
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
Chart Type:
Time Range:
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | W. CONSHOHOCKEN |
| Market Cap: | 45.2M | IPO Year: | N/A |
| Target Price: | $23.50 | AVG Volume (30 days): | 344.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.68 - $8.94 | Next Earning Date: | 11-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered MDCX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 20 hours ago
AI Recommendation
hold
Model Accuracy: 76.67%
76.67%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Medicus Pharma Ltd. Common Stock News
MDCX Breaking Stock News: Dive into MDCX Ticker-Specific Updates for Smart Investing
Compare MDCX vs Leading Stocks
See how MDCX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MDCX Medicus Pharma Ltd. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.